UniProt ID | NHLC1_HUMAN | |
---|---|---|
UniProt AC | Q6VVB1 | |
Protein Name | E3 ubiquitin-protein ligase NHLRC1 | |
Gene Name | NHLRC1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 395 | |
Subcellular Localization | Endoplasmic reticulum. Nucleus. Localizes at the endoplasmic reticulum and, to a lesser extent, in the nucleus. | |
Protein Description | E3 ubiquitin-protein ligase. Together with the phosphatase EPM2A/laforin, appears to be involved in the clearance of toxic polyglucosan and protein aggregates via multiple pathways. In complex with EPM2A/laforin and HSP70, suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system (UPS). Ubiquitinates the glycogen-targeting protein phosphatase subunits PPP1R3C/PTG and PPP1R3D in a laforin-dependent manner and targets them for proteasome-dependent degradation, thus decreasing glycogen accumulation. Polyubiquitinates EPM2A/laforin and ubiquitinates AGL and targets them for proteasome-dependent degradation. Also promotes proteasome-independent protein degradation through the macroautophagy pathway.. | |
Protein Sequence | MAAEASESGPALHELMREAEISLLECKVCFEKFGHRQQRRPRNLSCGHVVCLACVAALAHPRTLALECPFCRRACRGCDTSDCLPVLHLIELLGSALRQSPAAHRAAPSAPGALTCHHTFGGWGTLVNPTGLALCPKTGRVVVVHDGRRRVKIFDSGGGCAHQFGEKGDAAQDIRYPVDVTITNDCHVVVTDAGDRSIKVFDFFGQIKLVIGGQFSLPWGVETTPQNGIVVTDAEAGSLHLLDVDFAEGVLRRTERLQAHLCNPRGVAVSWLTGAIAVLEHPLALGTGVCSTRVKVFSSSMQLVGQVDTFGLSLYFPSKITASAVTFDHQGNVIVADTSGPAILCLGKPEEFPVPKPMVTHGLSHPVALTFTKENSLLVLDTASHSIKVYKVDWG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
176 | Phosphorylation | DAAQDIRYPVDVTIT CCCCCCCCCCEEEEE | 14.14 | 22210691 | |
181 | Phosphorylation | IRYPVDVTITNDCHV CCCCCEEEEECCCEE | 20.02 | 22210691 | |
183 | Phosphorylation | YPVDVTITNDCHVVV CCCEEEEECCCEEEE | 18.68 | 22210691 | |
197 | Phosphorylation | VTDAGDRSIKVFDFF EECCCCCEEEEEECC | 31.34 | 28555341 | |
309 | Phosphorylation | QLVGQVDTFGLSLYF CEEEEEECCCEEEEC | 22.27 | 22210691 | |
313 | Phosphorylation | QVDTFGLSLYFPSKI EEECCCEEEECCCCC | 22.77 | 22210691 | |
376 | Phosphorylation | LTFTKENSLLVLDTA EEEECCCEEEEEECC | 24.95 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NHLC1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NHLC1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NHLC1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GDE_HUMAN | AGL | physical | 17908927 | |
EPM2A_HUMAN | EPM2A | physical | 16115820 | |
EPM2A_HUMAN | EPM2A | physical | 15930137 | |
PPR3C_HUMAN | PPP1R3C | physical | 18070875 | |
DVL2_HUMAN | DVL2 | physical | 22223637 | |
NNAT_HUMAN | NNAT | physical | 21742036 | |
HSP74_HUMAN | HSPA4 | physical | 19892702 | |
EPM2A_HUMAN | EPM2A | physical | 18617530 | |
EPM2A_HUMAN | EPM2A | physical | 22578008 | |
PRDM8_HUMAN | PRDM8 | physical | 22961547 | |
UB2D3_HUMAN | UBE2D3 | physical | 22223637 | |
UBE2H_HUMAN | UBE2H | physical | 15930137 | |
UB2D1_HUMAN | UBE2D1 | physical | 15930137 | |
UB2D3_HUMAN | UBE2D3 | physical | 15930137 | |
UB2E1_HUMAN | UBE2E1 | physical | 15930137 | |
GYS1_HUMAN | GYS1 | physical | 22578008 | |
NHLC1_HUMAN | NHLRC1 | physical | 26648032 | |
EPM2A_HUMAN | EPM2A | physical | 26648032 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...